N Pedersen

1.5k total citations
10 papers, 583 citations indexed

About

N Pedersen is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, N Pedersen has authored 10 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in N Pedersen's work include Inflammatory Bowel Disease (5 papers), Pregnancy and Medication Impact (4 papers) and Reproductive System and Pregnancy (3 papers). N Pedersen is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Pregnancy and Medication Impact (4 papers) and Reproductive System and Pregnancy (3 papers). N Pedersen collaborates with scholars based in Denmark, United Kingdom and Netherlands. N Pedersen's co-authors include Sandro Ardizzone, C. Janneke van der Woude, Pascal Juillerat, Shaji Sebastian, Zuzana Zelinková, Gerald Fraser, A. Mulders, May‐Bente Bengtson, Sanja Kolaček and Andreas Sturm and has published in prestigious journals such as SHILAP Revista de lepidopterología, Alimentary Pharmacology & Therapeutics and Journal of Crohn s and Colitis.

In The Last Decade

N Pedersen

9 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N Pedersen Denmark 5 411 341 267 252 112 10 583
Jocelyn Miller United States 2 269 0.7× 232 0.7× 87 0.3× 140 0.6× 39 0.3× 6 346
David Sable United States 11 289 0.7× 50 0.1× 417 1.6× 161 0.6× 72 0.6× 21 1.2k
Ana Esteve‐Solé Spain 11 72 0.2× 269 0.8× 78 0.3× 41 0.2× 80 0.7× 27 370
Eleonor Tiblad Sweden 18 97 0.2× 173 0.5× 93 0.3× 88 0.3× 43 0.4× 44 803
J.‐F. Rahier Belgium 8 88 0.2× 190 0.6× 166 0.6× 114 0.5× 160 1.4× 14 446
Nicole B. Burger Netherlands 9 260 0.6× 110 0.3× 17 0.1× 54 0.2× 122 1.1× 24 460
Gert Datema Netherlands 14 141 0.3× 408 1.2× 28 0.1× 51 0.2× 83 0.7× 20 558
Ornela Kullolli Italy 8 159 0.4× 248 0.7× 20 0.1× 33 0.1× 36 0.3× 12 401
Alan P. Grailer United States 9 81 0.2× 356 1.0× 65 0.2× 211 0.8× 67 0.6× 16 679
J. Chabod France 13 58 0.1× 168 0.5× 50 0.2× 150 0.6× 33 0.3× 22 430

Countries citing papers authored by N Pedersen

Since Specialization
Citations

This map shows the geographic impact of N Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Pedersen more than expected).

Fields of papers citing papers by N Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Pedersen. The network helps show where N Pedersen may publish in the future.

Co-authorship network of co-authors of N Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of N Pedersen. A scholar is included among the top collaborators of N Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Pedersen. N Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Persson, Gry, et al.. (2025). Reduced expression of programmed cell death protein 1 on peripheral regulatory B cells in pre-eclampsia – Signs of impaired immune suppression. Journal of Reproductive Immunology. 168. 104426–104426. 2 indexed citations
2.
Pedersen, N, Thomas Scheike, Jens Ole Eriksen, et al.. (2024). Effect modification between HLA-F and CD56 markers reveals differences in survival for triple-negative breast cancer patients. Human Immunology. 85(6). 111152–111152.
4.
Juillerat, Pascal, et al.. (2020). Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic. Journal of Crohn s and Colitis. 14(Supplement_3). S807–S814. 5 indexed citations
5.
Bank, Steffen, Paal Skytt Andersen, Johan Burisch, et al.. (2014). Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease. The Pharmacogenomics Journal. 14(6). 526–534. 115 indexed citations
6.
Woude, C. Janneke van der, Sandro Ardizzone, May‐Bente Bengtson, et al.. (2014). The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 9(2). 107–124. 311 indexed citations
7.
Pedersen, N, et al.. (2014). P483 Faecal calprotectin exhibits diurnal variation in inflammatory bowel disease patients but is not affected by time of day. Journal of Crohn s and Colitis. 8. S268–S268. 2 indexed citations
8.
Bortoli, A., N Pedersen, Dana Ďuricová, et al.. (2011). Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Alimentary Pharmacology & Therapeutics. 34(7). 724–734. 126 indexed citations
9.
Ďuricová, Dana, N Pedersen, Martin Leníček, et al.. (2009). Infliximab dependency in children with Crohn’s disease. Alimentary Pharmacology & Therapeutics. 29(7). 792–799. 20 indexed citations
10.
Pedersen, N, Dana Ďuricová, & Margarita Elkjær. (2009). P219 - Overall and organ-specific extra-intestinal cancer in inflammatory bowel disease: a meta-analysis of population-based studies. Journal of Crohn s and Colitis. 3(1). S97–S97. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026